To answer Dr.EM_Chicago's question specifically:
From a clinical standpoint, VA healthcare GLP-1 access is an area where we have good evidence.
The short answer: baseline labs + quarterly monitoring is the standard of care.
The longer answer involves understanding the mechanism of action at the receptor level, which I am happy to elaborate on if helpful.
Same experience here with VA healthcare GLP-1. VendorMark described it perfectly.
OP here — wow, did not expect this much response! Thank you all for the thoughtful replies on VA healthcare GLP-1.
To answer nick_SD_fit: I started tracking everything in a spreadsheet from day 1.
Quick update: I will post a proper update thread soon. Thanks again for the evidence-based discussion — this is exactly why I posted in a science-based community. 🙏
Subscribing to this thread. VA healthcare GLP-1 is exactly what I've been researching. 🙏
Slightly tangential to VA healthcare GLP-1 but mark_tokyo reminded me — does anyone have experience combining this with metformin?
I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.